logo

Tag: NYSE: LLY
Trading Signals

Eli Lilly and Company (LLY) Becomes Attractive Again

Eli Lilly & Company (NYSE: LLY) has won clearance to market tirzepatide, a medicine that has the potential to change diabetes treatment. On May 17, LLY stock rose 2.66 percent to $299.38 in trading. Experts from the US Food and Drug Administration (FDA) agreed that

Investchronicle.com is an Economic news website, which offers broad information about the Stock markets and Equities. The major emphasis of this platform is to present, the most practical recommendation for public and private capital sharing, both in the form of updates and detailed analysis.
Facebook-f Twitter Google-plus-g Pinterest

Quick Links

Categories

All rights reserved © 2024, Powered By Smart TechOne

Invest Chronicle
Powered by  GDPR Cookie Compliance
Privacy Overview

This website uses cookies so that we can provide you with the best user experience possible. Cookie information is stored in your browser and performs functions such as recognising you when you return to our website and helping our team to understand which sections of the website you find most interesting and useful.